A citation-based method for searching scientific literature

Thomas Rose, Thomas Dörner. Best Pract Res Clin Rheumatol 2017
Times Cited: 16







List of co-cited articles
55 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus.
Tobias Alexander, Ramona Sarfert, Jens Klotsche, Anja A Kühl, Andrea Rubbert-Roth, Hannes-Martin Lorenz, Jürgen Rech, Bimba F Hoyer, Qingyu Cheng, Aderajew Waka,[...]. Ann Rheum Dis 2015
169
18

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.
Emily C Baechler, Franak M Batliwalla, George Karypis, Patrick M Gaffney, Ward A Ortmann, Karl J Espe, Katherine B Shark, William J Grande, Karis M Hughes, Vivek Kapur,[...]. Proc Natl Acad Sci U S A 2003
18

The 1982 revised criteria for the classification of systemic lupus erythematosus.
E M Tan, A S Cohen, J F Fries, A T Masi, D J McShane, N F Rothfield, J G Schaller, N Talal, R J Winchester. Arthritis Rheum 1982
18

The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis?
J Michelle Kahlenberg, Mariana J Kaplan. Curr Opin Rheumatol 2014
88
18

The genetics and molecular pathogenesis of systemic lupus erythematosus (SLE) in populations of different ancestry.
George N Goulielmos, Maria I Zervou, Vassilis M Vazgiourakis, Yogita Ghodke-Puranik, Alexandros Garyfallos, Timothy B Niewold. Gene 2018
35
18

CD5+ B lymphocytes in systemic lupus erythematosus patients: relation to disease activity.
Hanan Hassan Omar, Samah Ismail Nasef, Hamdy Hassan Omar, Mona Sayed Ghaly. Clin Rheumatol 2017
4
75

Systemic lupus erythematosus disease activity index 2000.
Dafna D Gladman, Dominique Ibañez, Murray B Urowitz. J Rheumatol 2002
18

Pathways leading to an immunological disease: systemic lupus erythematosus.
Olga Zharkova, Teja Celhar, Petra D Cravens, Anne B Satterthwaite, Anna-Marie Fairhurst, Laurie S Davis. Rheumatology (Oxford) 2017
62
12

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.
Brad H Rovin, Richard Furie, Kevin Latinis, R John Looney, Fernando C Fervenza, Jorge Sanchez-Guerrero, Romeo Maciuca, David Zhang, Jay P Garg, Paul Brunetta,[...]. Arthritis Rheum 2012
628
12

Regulation of autoantibody activity by the IL-23-TH17 axis determines the onset of autoimmune disease.
René Pfeifle, Tobias Rothe, Natacha Ipseiz, Hans U Scherer, Stephan Culemann, Ulrike Harre, Jochen A Ackermann, Martina Seefried, Arnd Kleyer, Stefan Uderhardt,[...]. Nat Immunol 2017
149
12

The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis.
Kirsten Neubert, Silke Meister, Katrin Moser, Florian Weisel, Damian Maseda, Kerstin Amann, Carsten Wiethe, Thomas H Winkler, Joachim R Kalden, Rudolf A Manz,[...]. Nat Med 2008
381
12


Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.
Sandra V Navarra, Renato M Guzmán, Alberto E Gallacher, Stephen Hall, Roger A Levy, Renato E Jimenez, Edmund K-M Li, Mathew Thomas, Ho-Youn Kim, Manuel G León,[...]. Lancet 2011
917
12

A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at University College London Hospital: the first fifty patients.
Tim Y-T Lu, Kristine P Ng, Geraldine Cambridge, Maria J Leandro, Jonathan C W Edwards, Michael Ehrenstein, David A Isenberg. Arthritis Rheum 2009
166
12


A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.
Richard Furie, Michelle Petri, Omid Zamani, Ricard Cervera, Daniel J Wallace, Dana Tegzová, Jorge Sanchez-Guerrero, Andreas Schwarting, Joan T Merrill, W Winn Chatham,[...]. Arthritis Rheum 2011
720
12

Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus.
Kayode J Bello, Hong Fang, Parastoo Fazeli, Waleed Bolad, Mary Corretti, Laurence S Magder, Michelle Petri. Rheumatol Int 2013
27
12

Effect of MaxEPA in patients with SLE. A double-blind, crossover study.
G Westberg, A Tarkowski. Scand J Rheumatol 1990
24
12

Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside.
D Squatrito, G Emmi, E Silvestri, L Ciucciarelli, M M D'Elios, D Prisco, L Emmi. Auto Immun Highlights 2014
19
12

Alterations in circulating fatty acid composition in patients with systemic lupus erythematosus: a pilot study.
Elaheh Aghdassi, David W L Ma, Stacey Morrison, Lynn M Hillyer, Shannon Clarke, Dafna D Gladman, Murray B Urowitz, Paul R Fortin. JPEN J Parenter Enteral Nutr 2011
15
13


The clinical effect of dietary supplementation with omega-3 fish oils and/or copper in systemic lupus erythematosus.
Emeir M Duffy, Gary K Meenagh, Stanley A McMillan, John J Strain, Bernadette M Hannigan, Aubrey L Bell. J Rheumatol 2004
51
12

American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis.
Bevra H Hahn, Maureen A McMahon, Alan Wilkinson, W Dean Wallace, David I Daikh, John D Fitzgerald, George A Karpouzas, Joan T Merrill, Daniel J Wallace, Jinoos Yazdany,[...]. Arthritis Care Res (Hoboken) 2012
667
12

The classification of glomerulonephritis in systemic lupus erythematosus revisited.
Jan J Weening, Vivette D D'Agati, Melvin M Schwartz, Surya V Seshan, Charles E Alpers, Gerald B Appel, James E Balow, Jan A Bruijn, Terence Cook, Franco Ferrario,[...]. Kidney Int 2004
731
12

Understanding the role of environmental factors in the development of systemic lupus erythematosus.
Christine G Parks, Aline de Souza Espindola Santos, Medha Barbhaiya, Karen H Costenbader. Best Pract Res Clin Rheumatol 2017
55
12


Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-κB-mediated inflammatory response.
Tao Jiang, Fei Tian, Hongting Zheng, Samantha A Whitman, Yifeng Lin, Zhigang Zhang, Nong Zhang, Donna D Zhang. Kidney Int 2014
114
12

The inflammasomes.
Kate Schroder, Jurg Tschopp. Cell 2010
12

Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus.
J Michelle Kahlenberg, Seth G Thacker, Celine C Berthier, Clemens D Cohen, Matthias Kretzler, Mariana J Kaplan. J Immunol 2011
110
12

Oxidative DNA and mitochondrial DNA change in patients with SLE.
Hui-Ting Lee, Tsai-Hung Wu, Chen-Sung Lin, Chyou-Shen Lee, Siao-Cian Pan, Deh-Ming Chang, Yau-Huei Wei, Chang-Youh Tsai. Front Biosci (Landmark Ed) 2017
8
25

Contribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosus.
Juan P Mackern-Oberti, Carolina Llanos, Claudia A Riedel, Susan M Bueno, Alexis M Kalergis. Immunology 2015
20
12

The pathogenesis of systemic lupus erythematosus - From the viewpoint of oxidative stress and mitochondrial dysfunction.
Hui-Ting Lee, Tsai-Hung Wu, Chen-Sung Lin, Chyou-Shen Lee, Yau-Huei Wei, Chang-Youh Tsai, Deh-Ming Chang. Mitochondrion 2016
26
12

Expanding the B Cell-Centric View of Systemic Lupus Erythematosus.
Peter A Morawski, Silvia Bolland. Trends Immunol 2017
19
12


Epigenetics in SLE.
Christian Michael Hedrich. Curr Rheumatol Rep 2017
35
12

NK cells dysfunction in systemic lupus erythematosus: relation to disease activity.
Ana Henriques, Luís Teixeira, Luís Inês, Tiago Carvalheiro, Ana Gonçalves, António Martinho, Maria Luísa Pais, José António Pereira da Silva, Artur Paiva. Clin Rheumatol 2013
33
12

The pathophysiologic role of monocytes and macrophages in systemic lupus erythematosus: a reappraisal.
Christina G Katsiari, Stamatis-Nick C Liossis, Petros P Sfikakis. Semin Arthritis Rheum 2010
109
12

Immunogenetics of systemic lupus erythematosus: A comprehensive review.
Yogita Ghodke-Puranik, Timothy B Niewold. J Autoimmun 2015
104
12

Alterations of oxygen consumption and extracellular acidification rates by glutamine in PBMCs of SLE patients.
Hui-Ting Lee, Chen-Sung Lin, Siao-Cian Pan, Tsai-Hung Wu, Chyou-Shen Lee, Deh-Ming Chang, Chang-Youh Tsai, Yau-Huei Wei. Mitochondrion 2019
10
20

Leukocyte mitochondrial DNA alteration in systemic lupus erythematosus and its relevance to the susceptibility to lupus nephritis.
Hui-Ting Lee, Chen-Sung Lin, Wei-Sheng Chen, Hsien-Tzung Liao, Chang-Youh Tsai, Yau-Huei Wei. Int J Mol Sci 2012
23
12

The innate immune system in human systemic lupus erythematosus.
Marc Weidenbusch, Onkar P Kulkarni, Hans-Joachim Anders. Clin Sci (Lond) 2017
17
12

What's wrong with neutrophils in lupus?
Chang-Youh Tsai, Ko-Jen Li, Song-Chou Hsieh, Hsien-Tzung Liao, Chia-Li Yu. Clin Exp Rheumatol 2019
7
28

Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
Baptiste Hervier, Vivien Beziat, Julien Haroche, Alexis Mathian, Pierre Lebon, Pascale Ghillani-Dalbin, Lucile Musset, Patrice Debré, Zahir Amoura, Vincent Vieillard. Arthritis Rheum 2011
69
12

Relationship between CD5+ B lymphocytes and the activity of systemic autoimmunity.
H Becker, C Weber, S Storch, K Federlin. Clin Immunol Immunopathol 1990
36
12

A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients.
Gal Yaniv, Gilad Twig, Dana Ben-Ami Shor, Ariel Furer, Yaniv Sherer, Oshry Mozes, Orna Komisar, Einat Slonimsky, Eyal Klang, Eyal Lotan,[...]. Autoimmun Rev 2015
153
12

Clinical relevance of circulating anti-ENA and anti-dsDNA secreting cells from SLE patients and their dependence on STAT-3 activation.
Raquel de la Varga Martínez, Beatriz Rodríguez-Bayona, Gustavo A Añez, Fermín Medina Varo, José J Pérez Venegas, José A Brieva, Carmen Rodríguez. Eur J Immunol 2017
14
14

Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus.
Richard Furie, Munther Khamashta, Joan T Merrill, Victoria P Werth, Kenneth Kalunian, Philip Brohawn, Gabor G Illei, Jorn Drappa, Liangwei Wang, Stephen Yoo. Arthritis Rheumatol 2017
336
12

Intrarenal activation of adaptive immune effectors is associated with tubular damage and impaired renal function in lupus nephritis.
Cristina Pamfil, Zuzanna Makowska, Aurélie De Groof, Gaëlle Tilman, Sepideh Babaei, Christine Galant, Pauline Montigny, Nathalie Demoulin, Michel Jadoul, Selda Aydin,[...]. Ann Rheum Dis 2018
15
13

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial.
Daniel J Wallace, Richard A Furie, Yoshiya Tanaka, Kenneth C Kalunian, Marta Mosca, Michelle A Petri, Thomas Dörner, Mario H Cardiel, Ian N Bruce, Elisa Gomez,[...]. Lancet 2018
151
12

Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.
George K Bertsias, Maria Tektonidou, Zahir Amoura, Martin Aringer, Ingeborg Bajema, Jo H M Berden, John Boletis, Ricard Cervera, Thomas Dörner, Andrea Doria,[...]. Ann Rheum Dis 2012
539
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.